Nazareth, Belgium

Jos Raymackers

This inventor holds 1 USPTO granted patent. Top assignee: Innogenetics N.v.. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jos Raymackers: Innovator in Pharmaceutical Compositions

Introduction

Jos Raymackers is a notable inventor based in Nazareth, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating skin wounds. His innovative work has led to the creation of a patented polypeptide with unique properties.

Latest Patents

Raymackers holds a patent titled "Form of amphiregulin, methods for producing and using the same and compositions comprising the same." This patent describes an isolated and purified polypeptide that possesses heparin binding properties, specifically with the amino acid sequence of SQ ID No: 1. The patent also includes pharmaceutical compositions aimed at effectively treating skin wounds. He has 1 patent to his name.

Career Highlights

Jos Raymackers is associated with Innogenetics N.V., a company known for its advancements in biotechnology and pharmaceuticals. His work at Innogenetics has allowed him to focus on innovative solutions that address medical challenges.

Collaborations

Throughout his career, Raymackers has collaborated with esteemed colleagues such as Bernard Delaey and Hugo Van Heuverswyn. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.

Conclusion

Jos Raymackers is a distinguished inventor whose work in pharmaceutical compositions has made a significant impact in the field. His patented innovations continue to contribute to advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…